Health Sciences Acquisitions Corporation 2
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Health Sciences Acquisitions Corporation 2 generated cash of -$1,579,299, which is less than the previous year. Cash used in financing activities reached the amount of -$92,591,090 last year. Net change in cash is therefore -$1,579,299.
Cash Flow
| 2020 | -258.50K | -160M | 162.28M |
|---|---|---|---|
| 2021 | -272.36K | 0 | 0 |
| 2022 | -1.57M | 92.59M | -92.59M |
HSAQ Cash Flow Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 1.75M | 2.02M | 0 |
Operating activities | |||
Net income | -2.73M | -378.75K | -173.54K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 0 | 0 | 0 |
Stock-based compensation expense | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 375.54K | -12.42K | 13.81K |
Cash generated by operating activities | -1.57M | -272.36K | -258.50K |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | 92.59M | 0 | -160M |
Financing activities | |||
Common Stock Issued | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | -92.59M | 0 | 162.28M |
Net Change In Cash | -1.57M | -272.36K | 2.02M |
Cash at end of period | 175.16K | 1.75M | 2.02M |
| Data source | Data source | Data source |